BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7539881)

  • 1. An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma.
    Haratake J; Hashimoto H
    Liver; 1995 Feb; 15(1):9-15. PubMed ID: 7539881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An immunohistochemical study on primary carcinoma of the liver].
    Seo JK
    J UOEH; 1989 Dec; 11(4):429-39. PubMed ID: 2481871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical study of sarcomatoid liver carcinomas.
    Haratake J; Horie A
    Cancer; 1991 Jul; 68(1):93-7. PubMed ID: 1710948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
    Tsuji M; Kashihara T; Terada N; Mori H
    Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
    Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
    Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
    Ma CK; Zarbo RJ; Frierson HF; Lee MW
    Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.
    Herrmann G
    Z Gastroenterol; 1999 May; 37(5):329-42. PubMed ID: 10413841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases.
    Kilpatrick SE; Geisinger KR; Loggie BW; Hopkins MB
    Acta Cytol; 1993; 37(6):943-7. PubMed ID: 7504382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.
    Itoyama M; Hata M; Yamanegi K; Yamada N; Ohyama H; Hirano H; Terada N; Nakasho K
    Med Mol Morphol; 2012 Dec; 45(1):7-13. PubMed ID: 22431178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
    Goodman ZD; Ishak KG; Langloss JM; Sesterhenn IA; Rabin L
    Cancer; 1985 Jan; 55(1):124-35. PubMed ID: 2578078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients.
    Nagafuchi Y; Okamoto K; Shono M; Higure A; Todoroki H; Itoh H; Takeda S; Katumoto F; Toyoshima S
    Hepatogastroenterology; 1998; 45(20):523-7. PubMed ID: 9638442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one nodule.
    Kano Y; Kakinuma S; Goto F; Azuma S; Nishimura-Sakurai Y; Itsui Y; Nakagawa M; Kudo A; Tanabe M; Kirimura S; Amano T; Ito T; Akashi T; Asahina Y; Watanabe M
    Clin J Gastroenterol; 2014 Oct; 7(5):449-54. PubMed ID: 26184027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
    Xu J; Zhang C; Qiao A; Xi Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas.
    Imai Y; Oda H; Arai M; Shimizu S; Nakatsuru Y; Inoue T; Ishikawa T
    Jpn J Cancer Res; 1996 Oct; 87(10):1056-62. PubMed ID: 8957064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic study on cholangiolocellular carcinoma.
    Shiota K; Taguchi J; Nakashima O; Nakashima M; Kojiro M
    Oncol Rep; 2001; 8(2):263-8. PubMed ID: 11182037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
    Chu PG; Ishizawa S; Wu E; Weiss LM
    Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
    Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin.
    Martín de las Mulas J; Gómez-Villamandos JC; Pérez J; Mozos E; Estrado M; Méndez A
    Res Vet Sci; 1995 Sep; 59(2):124-7. PubMed ID: 8525100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.